Sativex has no long-term negative effect on MS cognition
Sativex has no long-term negative effect on MS cognition
GW Pharmaceuticals plc announced top-line results from a 12 month placebo-controlled study of Sativex in patients with spasticity due to Multiple Sclerosis (MS). The study results confirm the reassuring safety profile of Sativex and provide further evidence of long-term efficacy...... Read More - http://www.securio.net/msuk/index.cfm/sativex
MS-UK - http://www.ms-uk.org/